Ardent Health Partners (NYSE:ARDT) Given “Overweight” Rating at Stephens

Ardent Health Partners (NYSE:ARDT)‘s stock had its “overweight” rating reiterated by research analysts at Stephens in a research report issued on Wednesday,Benzinga reports. They presently have a $22.00 price target on the stock. Stephens’ price target indicates a potential upside of 67.26% from the company’s current price.

A number of other research analysts also recently commented on ARDT. Royal Bank of Canada reduced their target price on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Tuesday, March 4th. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, January 6th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Morgan Stanley decreased their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Ardent Health Partners presently has an average rating of “Buy” and an average price target of $21.18.

Ardent Health Partners Trading Up 0.3 %

Shares of NYSE:ARDT opened at $13.15 on Wednesday. The company has a fifty day simple moving average of $14.43 and a 200 day simple moving average of $16.28. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a 12-month low of $12.87 and a 12-month high of $20.72.

Ardent Health Partners (NYSE:ARDT) last released its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion. Analysts expect that Ardent Health Partners will post 1.23 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Ventas Inc. bought a new stake in shares of Ardent Health Partners during the fourth quarter valued at approximately $159,570,000. Wellington Management Group LLP bought a new stake in Ardent Health Partners during the 3rd quarter valued at $28,724,000. Point72 Asset Management L.P. acquired a new position in Ardent Health Partners during the 3rd quarter worth $27,428,000. Goldentree Asset Management LP bought a new position in shares of Ardent Health Partners in the third quarter worth $22,897,000. Finally, Franklin Resources Inc. acquired a new position in shares of Ardent Health Partners during the third quarter valued at $15,839,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.